To assess the predictive and prognostic aim of interim and end-treatment F-fluorocholine PET/CT (FCH-PET/CT) and Tc-methilen diphosphonate bone scintigraphy (BS) in patients with castration-resistant prostate cancer and bone metastases (CRPC-BM) treated with Radium 223 dichloride (Ra). Prospective and multicentre ChoPET-Rad study including 82 patients with CRPC-BM. Baseline, after 3 (interim) and 6 doses (end-treatment) BS and FCH PET/CT were performed in patients who meet the study criteria. Clinical variables, imaging and clinical progression were obtained and their association with progression free survival (PFS), and overall survival (OS) was studied. Agreement between BS and FCH PET/CT response was assessed using Kappa (K) analysis. Median of PFS and OS was 3 and 16 months, respectively. Agreement between interim BS and FCH PET/CT was weak (K: 0.28; p = 0.004). No agreement was observed between end-treatment diagnostic studies. Interim and end-treatment FCH PET/CT were related to PFS (p = 0.011 and p < 0.001, respectively). Therapeutic failure and interim BS and FCH PET/CT showed association with OS (p < 0.001, p = 0.037 and p = 0.008, respectively). Interim and end-treatment FCH PET/CT were good predictors of biochemical progression in patients treated with Ra. Therapeutic failure and progression in interim BS or FCH PET/CT were adverse factors for OS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016973 | PMC |
| http://dx.doi.org/10.1038/s41598-021-86759-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[F]fluorocholine PET . [Tc]sestamibi scintigraphy for detection and localization of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism: outcomes and resource efficiency.
Radiol Oncol
December 2024
Division of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Article Synopsis
- - Minimally invasive parathyroidectomy is the preferred treatment for primary hyperparathyroidism, but it relies on effective preoperative localization methods to identify overactive parathyroid tissue.
- - A study compared two groups of patients—234 who had traditional MIBI scintigraphy and 163 who had FCh-PET/CT—focusing on the efficiency and outcomes of these imaging techniques leading up to surgery.
- - Results showed that FCh-PET/CT significantly reduced imaging time by 83% and surgery time by 41% without using intraoperative hormone monitoring, suggesting it may lead to faster procedures and fewer reoperations for patients.
Diagnostic Performances of F-Fluorocholine PET/CT as First-Line Functional Imaging Method for Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism.
Acad Radiol
October 2024
Nuclear Medicine Department, Centre Georges François Leclerc, 21000 Dijon, France. Electronic address:
Article Synopsis
- This study assessed the effectiveness of F-fluorocholine (FCH) PET/CT for locating hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism (PHPT) before surgery.
- The research involved 80 patients who underwent FCH PET/CT, comparing the imaging results with histological findings and postoperative outcomes to evaluate the method's diagnostic performance.
- Results showed that FCH PET/CT had a sensitivity of 88% and a positive predictive value of 91%, indicating it is a valuable tool for pre-surgical localization of problematic parathyroid tissue in PHPT patients.*
A challenging diagnosis of prostate cancer seeding in the perineal needle-tract after transperineal biopsy: is PET-CT the imaging of choice?
Urol Case Rep
November 2024
Department of Surgical Sciences, Urology Unit, University of Rome Tor Vergata, AOU Policlinico Tor Vergata, Rome, Italy.
Perineal seeding is an extremely rare complication after prostate biopsy. We found a perineal localization of prostatic adenocarcinoma 5 years after the transperineal biopsy in a patient with metastatic castration resistant prostate cancer. The tumor was identified by aF-Fluorocholin positron emission tomography-computed tomography (F-FCH PET-CT) performed after a sudden rise of PSA levels during androgen deprivation therapy and after a negative CT scan.
View Article and Find Full Text PDFIncidental Detection of Brain Metastases From a Pulmonary Large Cell Neuroendocrine Carcinoma at 18 F-Fluorocholine PET/CT in a Context of Primary Hyperparathyroidism.
Clin Nucl Med
November 2024
Nuclear Medicine Department, Centre Georges François Leclerc, Dijon, France.
Article Synopsis
- A 65-year-old man with hypercalcemia due to hyperparathyroidism was sent for an 18 F-fluorocholine PET/CT to find abnormal parathyroid glands.
- The imaging unexpectedly showed a brain metastasis from a pulmonary large cell neuroendocrine carcinoma along with a parathyroid adenoma.
- This case highlights how FCH PET/CT can be useful in assessing hyperparathyroidism and can also uncover hidden cancers.
F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
Semin Nucl Med
November 2024
Service de médecine nucléaire, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France; Institut National des Sciences et Techniques Nucléaires (INSTN), Saclay, France.
Article Synopsis
- Preoperative imaging for patients with hyperparathyroidism aids in planning surgeries, especially minimizing invasive techniques like minimally invasive parathyroidectomy (MIPTX), which has benefits like shorter surgery times and reduced risks.
- FCH PET/CT scans have shown to have a high sensitivity (97%) for detecting abnormal parathyroid glands, outperforming other imaging methods, which leads to lower rates of surgery failure.
- The article reviews the use of FCH PET/CT in diagnosing and guiding treatment for hyperparathyroidism, emphasizing its safety and effectiveness over a 12-year real-world experience supporting its use as the preferred imaging choice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!